Medicare Enrolled

Dr. Robert Beaulieu, MD

Ophthalmology · Royal Oak, MI
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
3535 W 13 MILE RD STE 555, Royal Oak, MI 48073
2485512020
Registered in NPPES since 2014
NPI: 1750700746 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Beaulieu from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Beaulieu? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Beaulieu

Dr. Robert Beaulieu is an ophthalmology specialist in Royal Oak, MI, with 12 years of NPI registration. Based on federal Medicare data, Dr. Beaulieu performed 5,505 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Beaulieu received a total of $3,676 from 10 pharmaceutical and/or device companies across 49 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Beaulieu is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years of NPI registration ▲ Top 11% volume in MI $3,676 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
5,505
Medicare services
Top 11% in MI for ophthalmology
Not available
Unique patients (not deduplicated)
$28
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection, per unit
An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered.
4,400 $5 $10
Microfluid analysis of tears
A laboratory test that analyzes tear fluid using microfluidic technology to measure specific biomarkers. This procedure helps evaluate the composition of tears for diagnostic purposes.
214 $22 $40
Eye photography
Photographic imaging of the interior structures of the eye.
183 $17 $51
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
176 $119 $243
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
90 $94 $191
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
71 $66 $135
Visual field test, intermediate
A test that measures your side vision to check for blind spots or other vision changes.
68 $35 $130
Upper eyelid tendon repair
Surgical repair of the tendon in the upper eyelid to restore its function and structure.
55 $606 $1,743
Nasal tear duct probing
A procedure to examine and clear the tear ducts in the nose. It helps restore normal drainage of tears from the eye.
45 $117 $278
Chemical nerve block for facial paralysis
Injection of a chemical agent to paralyze specific nerves or muscles on the side of the face.
44 $124 $282
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
35 $81 $145
Removal of excessive skin and fat of upper eyelid 30 $580 $1,592
Visual field test, limited
A test that measures your side (peripheral) vision. This limited version assesses a restricted portion of your visual field.
20 $25 $70
Extensive repair of turning-outward eyelid defect
A surgical procedure to correct an eyelid that turns outward. The repair addresses defects in the eyelid structure to restore normal function and appearance.
17 $270 $1,562
Extensive repair of turning-inward eyelid defect
A surgical procedure to correct an eyelid that turns inward. The repair addresses defects in the eyelid structure to restore normal function and appearance.
17 $310 $965
Skin graft repair of eyelid, nose, ear, or lip, 10 sq cm or less
A surgical procedure to repair a wound on the eyelid, nose, ear, or lip by transferring a small piece of skin. The transferred skin covers an area of 10 square centimeters or less.
14 $499 $1,416
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
14 $47 $123
Correction of widely-opened upper eyelid
A surgical procedure to adjust the upper eyelid to correct a condition where it remains excessively open.
12 $382 $1,097
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,676
Total received (2018-2024)
Avg $525/year across 7 years
Top 21% in MI for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
10
Companies
49
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$287
2023
$483
2022
$1,512
2021
$394
2020
$148
2019
$147
2018
$705

Payments by company (2024)

Alcon Vision LLC
$162
Kerecis Limited
$125
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Horizon Therapeutics plc
$1,683
Alcon Laboratories Inc
$705
Alcon Vision LLC
$533
TISSUETECH, INC.
$250
Genentech USA, Inc.
$145
Kerecis Limited
$125
Aerie Pharmaceuticals, Inc.
$119
Zimmer Biomet Holdings, Inc.
$62
Bausch & Lomb, a division of Bausch Health US, LLC
$31
Sun Pharmaceutical Industries Inc.
$22
Top 3 companies account for 79.5% of all-time payments
Associated products mentioned in payments ›
ACTIVEFOCUS · AcrySof · Centurion · Cequa · Clareon · Erivedge · Kerecis Omega3 SurgiClose · LOTEMAX SM · Luxor · PROKERA · ROSA · TEPEZZA · rocklatan
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an ophthalmology specialist in Royal Oak?
Compare ophthalmologists in the Royal Oak area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists in nearby ZIP areas
354
County median income
$95,296
Nearest hospital to ZIP centroid (approximate)
BEAUMONT HOSPITAL ROYAL OAK
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Beaulieu is a mixed practice specialist, with above-average Medicare volume (top 11% in MI).

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Beaulieu experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Beaulieu performed 4,400 botox injection, per unit services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Beaulieu receive payments from pharmaceutical companies?
Yes. Dr. Beaulieu received a total of $3,676 from 10 companies across 49 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Beaulieu's costs compare to other ophthalmologists in Royal Oak?
Dr. Beaulieu's average Medicare payment per service is $28. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Beaulieu) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →